192 related articles for article (PubMed ID: 2174530)
1. [Autoradiographic localization and characterization of the ocular binding sites of the VIP (vasoactive intestinal peptide) in albino rats and rabbits].
Denis P; Dussaillant M; Elena PP; Nordmann JP; Rostene W; Laroche L
Ophtalmologie; 1990; 4(1):30-2. PubMed ID: 2174530
[TBL] [Abstract][Full Text] [Related]
2. Autoradiographic characterization and localization of vasoactive intestinal peptide binding sites in albino rat and rabbit eyes.
Denis P; Dussaillant M; Nordmann JP; Elena PP; Saraux H; Rostene W
Exp Eye Res; 1991 Mar; 52(3):357-66. PubMed ID: 2015864
[TBL] [Abstract][Full Text] [Related]
3. Localization and characterization of substance P binding sites in rat and rabbit eyes.
Denis P; Fardin V; Nordmann JP; Elena PP; Laroche L; Saraux H; Rostene W
Invest Ophthalmol Vis Sci; 1991 May; 32(6):1894-902. PubMed ID: 1709627
[TBL] [Abstract][Full Text] [Related]
4. Distribution of vasoactive intestinal polypeptide (VIP) binding in circular muscle and characterization of VIP binding in canine small intestinal mucosa.
Mao YK; Barnett W; Coy DH; Tougas G; Daniel EE
J Pharmacol Exp Ther; 1991 Sep; 258(3):986-91. PubMed ID: 1653848
[TBL] [Abstract][Full Text] [Related]
5. Vasoactive intestinal peptide and intraocular pressure: adenylate cyclase activation and binding sites for vasoactive intestinal peptide in membranes of ocular ciliary processes.
Mittag TW; Tormay A; Podos SM
J Pharmacol Exp Ther; 1987 Apr; 241(1):230-5. PubMed ID: 3033201
[TBL] [Abstract][Full Text] [Related]
6. Receptors for vasoactive intestinal peptide in rat anterior pituitary glands: localization of binding to lactotropes.
Wanke IE; Rorstad OP
Endocrinology; 1990 Apr; 126(4):1981-8. PubMed ID: 2156675
[TBL] [Abstract][Full Text] [Related]
7. Characterization of vasoactive intestinal peptide receptors in rabbit ciliary processes.
Horio B; Law NM; Rosenzweig SA
Invest Ophthalmol Vis Sci; 1995 Jan; 36(1):192-9. PubMed ID: 7529752
[TBL] [Abstract][Full Text] [Related]
8. Visualization of vasoactive intestinal peptide receptors in human and guinea pig lung.
Carstairs JR; Barnes PJ
J Pharmacol Exp Ther; 1986 Oct; 239(1):249-55. PubMed ID: 3020233
[TBL] [Abstract][Full Text] [Related]
9. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
Zawilska JB; Niewiadomski P; Nowak JZ
Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
[TBL] [Abstract][Full Text] [Related]
10. Autoradiographic localization of vasoactive intestinal polypeptide receptors in the rat mesenteric vascular tree.
Amenta F; Cavallotti C; Collier WL; Ferrante F; Geppetti P; Ricci A
Regul Pept; 1989 Aug; 26(1):9-17. PubMed ID: 2554372
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the vasoactive intestinal peptide receptor in rat submandibular gland: radioligand binding assay in membrane preparations.
Turner JT; Bylund DB
J Pharmacol Exp Ther; 1987 Sep; 242(3):873-81. PubMed ID: 2821229
[TBL] [Abstract][Full Text] [Related]
12. Vasoactive intestinal peptide binding sites and fibers in the brain of the pigeon Columba livia: an autoradiographic and immunohistochemical study.
Hof PR; Dietl MM; Charnay Y; Martin JL; Bouras C; Palacios JM; Magistretti PJ
J Comp Neurol; 1991 Mar; 305(3):393-411. PubMed ID: 1645376
[TBL] [Abstract][Full Text] [Related]
13. Properties of vasoactive intestinal peptide-receptor interaction in rat liver membranes.
Guerrero JM; Prieto JC; Ramírez-Cárdenas R; Calvo JR; Goberna R
Rev Esp Fisiol; 1981 Mar; 37(1):1-8. PubMed ID: 6113623
[TBL] [Abstract][Full Text] [Related]
14. Selectivity for binding of peptide analogs to vascular receptors for vasoactive intestinal peptide.
Rorstad OP; Wanke I; Coy DH; Fournier A; Huang M
Mol Pharmacol; 1990 Jun; 37(6):971-7. PubMed ID: 2163020
[TBL] [Abstract][Full Text] [Related]
15. Study of species specificity in growth hormone-releasing factor (GRF) interaction with vasoactive intestinal peptide (VIP) receptors using GRF and intestinal VIP receptors from rat and human: evidence that Ac-Tyr1hGRF is a competitive VIP antagonist in the rat.
Laburthe M; Couvineau A; Rouyer-Fessard C
Mol Pharmacol; 1986 Jan; 29(1):23-7. PubMed ID: 3003561
[TBL] [Abstract][Full Text] [Related]
16. Autoradiographic analysis of the distribution of vasoactive intestinal peptide binding sites in the vertebrate central nervous system: a phylogenetic study.
Dietl MM; Hof PR; Martin JL; Magistretti PJ; Palacios JM
Brain Res; 1990 Jun; 520(1-2):14-26. PubMed ID: 2169952
[TBL] [Abstract][Full Text] [Related]
17. Vasoactive intestinal polypeptide receptors in rat cerebral vessels: an autoradiographic study.
Amenta F; Cavalotti C; De Michele M; De Vincentis G; Rossodivita A; Rossodivita I
J Auton Pharmacol; 1991 Oct; 11(5):285-93. PubMed ID: 1660895
[TBL] [Abstract][Full Text] [Related]
18. Characterization and localization of vasoactive intestinal peptide receptors in the rat lung.
Leroux P; Vaudry H; Fournier A; St-Pierre S; Pelletier G
Endocrinology; 1984 May; 114(5):1506-12. PubMed ID: 6325122
[TBL] [Abstract][Full Text] [Related]
19. Characterization of ocular receptors for pituitary adenylate cyclase activating polypeptide (PACAP) and their coupling to adenylate cyclase.
Nilsson SF; De Neef P; Robberecht P; Christophe J
Exp Eye Res; 1994 Apr; 58(4):459-67. PubMed ID: 7925682
[TBL] [Abstract][Full Text] [Related]
20. Modifications of the binding properties of the human VIP receptor of IGR39 cells by sulfhydryl reagents.
Fouchier F; Forget P; Pic P; Marvaldi J; Pichon J
Eur J Cell Biol; 1992 Dec; 59(2):382-8. PubMed ID: 1337321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]